The Role of Liquid Biopsy in Early Diagnosis of Lung Cancer

Data de publicação:

Autores da FMUP

  • Venceslau José Coelho Pinto Hespanhol

    Autor

Participantes de fora da FMUP

  • Freitas, Claudia
  • Sousa, Catarina
  • Machado, Francisco
  • Serino, Mariana
  • Santos, Vanessa
  • Cruz-Martins, Natalia
  • Teixeira, Armando
  • Cunha, Antonio
  • Pereira, Tania
  • Oliveira, Helder P.
  • Costa, Jose Luis

Unidades de investigação

Abstract

Liquid biopsy is an emerging technology with a potential role in the screening and early detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and are currently under ongoing investigation. In this article, we review the available data on the use of circulating biomarkers for the early detection of lung cancer, focusing on the circulating tumor cells, circulating cell-free DNA, circulating micro-RNAs, tumor-derived exosomes, and tumor-educated platelets, providing an overview of future potential applicability in the clinical practice. While several biomarkers have shown exciting results, diagnostic performance and clinical applicability is still limited. The combination of different biomarkers, as well as their combination with other diagnostic tools show great promise, although further research is still required to define and validate the role of liquid biopsies in clinical practice.

Dados da publicação

ISSN/ISSNe:
2234-943X, 2234-943X

Frontiers in Oncology  Frontiers Media S.A.

Tipo:
Review
Páginas:
-
PubMed:
33937034
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 66

Citações Recebidas na Scopus: 69

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • lung cancer; clinical biomarkers detection; liquid biopsy; cell-free DNA; exosomes; tumor-educated platelets; circulating tumor associated cells

Projetos associados

Doença do Refluxo Gastro-esofágico e Doença Pulmonar

Investigador Principal: Venceslau José Coelho Pinto Hespanhol

Estudo Clínico Académico (Refluxo Gastro-esofágic) . 2020

A importância do diagnóstico na Fibrose Pulmonar Idiopática

Investigador Principal: Venceslau José Coelho Pinto Hespanhol

Estudo Clínico Académico (FPI) . 2020

Imunoterapia no cancro do pulmão: PD-L1, biomarcador preditivo?

Investigador Principal: Venceslau José Coelho Pinto Hespanhol

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação